CDKL5 and craniodiaphyseal dysplasia: We based on the assumption that gaining a deeper understanding of the overall spectrum and natural history of the CDD disease (and the associated pathogenetic variants in CDKL5) would be pivotal to personalized genetic counseling and clinical management of the affected children, particularly with the increasing possibilities in molecular and genetic diagnoses and, potentially, targeted treatments.